777P A phase II study of the efficacy of olaparib maintenance monotherapy for patients with HRD-positive, newly diagnosed, advanced, high-grade ovarian cancer, evaluated by whole-exome sequencing (MSBM-OL)

Katsutoshi Oda, K. Hasegawa, Masahiko Mori et al.|Annals of Oncology|2024

Cited by 0